Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-26 @ 3:25 AM
Study NCT ID:
NCT05872620
Status:
COMPLETED
Last Update Posted:
2025-09-18
First Post:
2023-05-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-15
First Submit QC Date:
None
Study First Post Date:
2023-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-17
Last Update Post Date:
2025-09-18
Last Update Post Date Type:
ESTIMATED